22
Views
110
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Tumor Promoter Arsenite Activates Extracellular Signal-Regulated Kinase through a Signaling Pathway Mediated by Epidermal Growth Factor Receptor and Shc

, , &
Pages 5178-5188 | Received 29 Dec 1997, Accepted 18 Jun 1998, Published online: 28 Mar 2023

REFERENCES

  • Angel, P., and M. Karin 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072: 129–157.
  • Avruch, J., X. F. Zhang, and J. M. Kyriakis 1994. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci. 19: 279–283.
  • Bagla, P., and J. Kaiser 1996. India’s spreading health crisis draws global arsenic experts. Science 274: 174–175.
  • Bonfini, L., E. Migliaccio, G. Pelicci, L. Lanfrancone, and P. G. Pelicci 1996. Not all Shc’s roads lead to Ras. Trends Biochem. Sci. 21: 257–261.
  • Carpenter, G., and S. Cohen 1976. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J. Cell Biol. 71: 159–171.
  • Cavigelli, M., W. W. Li, A. Lin, B. Su, K. Yoshioka, and M. Karin 1996. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 15: 6269–6279.
  • Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841–852.
  • Cuzick, J., S. Evans, M. Gillman, and E. D. Price 1982. Medicinal arsenic and internal malignancies. Br. J. Cancer 45: 904–911.
  • Cuzick, J., P. Sasieni, and S. Evans 1992. Ingested arsenic, keratoses, and bladder cancer. Am. J. Epidemiol. 136: 417–421.
  • Daub, H., F. U. Weiss, C. Wallasch, and A. Ullrich 1996. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379: 557–560.
  • Davis, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268: 14553–14556.
  • Devary, Y., R. A. Gottlieb, T. Smeal, and M. Karin 1992. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71: 1081–1091.
  • Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92: 7686–7689.
  • Egan, S. E., and R. A. Weinberg 1993. The pathway to signal achievement. Nature 365: 781–783.
  • Feig, L. A. 1993. The many roads that lead to Ras. Science 260: 767–768.
  • Germolec, D. R., T. Yoshida, K. Gaido, J. L. Wilmer, P. P. Simeonova, F. Kayama, F. Burleson, W. Dong, R. W. Lange, and M. I. Luster 1996. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol. Appl. Pharmacol. 141: 308–318.
  • Gorospe, M., Y. Liu, Q. Xu, F. J. Chrest, and N. J. Holbrook 1996. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol. Cell. Biol. 16: 762–770.
  • Gotoh, Y., E. Nishida, and H. Sakai 1990. Okadaic acid activates microtubule-associated protein kinase in quiescent fibroblastic cells. Eur. J. Biochem. 193: 671–674.
  • Gullick, W. J. 1996. The c-erbB3/HER3 receptor in human cancer. Cancer Surv. 27: 339–349.
  • Guyton, K. Z., M. Gorospe, T. W. Kensler, and N. J. Holbrook 1996. Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implications for cellular survival and tumor promotion. Cancer Res. 56: 3480–3485.
  • Guyton, K. Z., M. Gorospe, X. Wang, Y. D. Mock, G. C. Kokkonen, Y. Liu, G. S. Roth, and N. J. Holbrook. Age-related changes in activation of mitogen activated protein kinase cascades by oxidative stress. J. Invest. Dermatol. Symp. Proc., in press.
  • Guyton, K. Z., Y. Liu, M. Gorospe, Q. Xu, and N. J. Holbrook 1996. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J. Biol. Chem. 271: 4138–4142.
  • Hartwig, A., U. D. Groblinghoff, D. Beyersmann, A. T. Natarajan, R. Filon, and L. H. Mullenders 1997. Interaction of arsenic (III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis 18: 399–405.
  • Heldin, C. H. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80: 213–223.
  • Huang, R. P., J. X. Wu, Y. Fan, and E. D. Adamson 1996. UV activates growth factor receptors via reactive oxygen intermediates. J. Cell Biol. 133: 211–220.
  • Johansson, S. L., and S. M. Cohen 1997. Epidemiology and etiology of bladder cancer. Semin. Surg. Oncol. 13: 291–298.
  • Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483–16486.
  • Knebel, A., H. J. Rahmsdorf, A. Ullrich, and P. Herrlich 1996. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 15: 5314–5325.
  • Kolch, W., G. Heidecker, G. Kochs, R. Hummel, H. Vahidi, H. Mischak, G. Finkenzeller, D. Marme, and U. R. Rapp 1993. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364: 249–252.
  • Kyriakis, J. M., and J. Avruch 1996. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18: 567–577.
  • Lander, J. J., R. J. Stanley, H. W. Sumner, D. C. Boswell, and R. D. Aach 1975. Angiosarcoma of the liver associated with Fowler’s solution (potassium arsenite). Gastroenterology 68: 1582–1586.
  • Lengyel, E., H. Wang, R. Gum, C. Simon, Y. Wang, and D. Boyd 1997. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Oncogene 14: 2563–2573.
  • Levitzki, A., and A. Gazit 1995. Tyrosine kinase inhibition: an approach to drug development. Science 267: 1782–1788.
  • Li, J. H., and T. G. Rossman 1989. Mechanism of comutagenesis of sodium arsenite with n-methyl-n-nitrosourea. Biol. Trace Elem. Res. 21: 373–381.
  • Liu, Y., M. Gorospe, C. Yang, and N. J. Holbrook 1995. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J. Biol. Chem. 270: 8377–8380.
  • Liu, Y., K. Z. Guyton, M. Gorospe, Q. Xu, G. C. Kokkonen, Y. D. Mock, G. S. Roth, and N. J. Holbrook 1996. Age-related decline in mitogen-activated protein kinase activity in epidermal growth factor-stimulated rat hepatocytes. J. Biol. Chem. 271: 3604–3607.
  • Liu, Y., K. Z. Guyton, M. Gorospe, Q. Xu, J. C. Lee, and N. J. Holbrook 1996. Differential activation of ERK, JNK/SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite. Free Radical Biol. Med. 21: 771–781.
  • Lupu, R., M. Cardillo, L. Harris, M. Hijazi, and K. Rosenberg 1995. Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance. Semin. Cancer Biol. 6: 135–145.
  • Luttrell, L. M., R. G. Della, B. T. van, D. K. Luttrell, and R. J. Lefkowitz 1997. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 272: 4637–4644.
  • Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, W. G. Vande, and N. G. Ahn 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966–970.
  • Masui, H., L. Castro, and J. Mendelsohn 1993. Consumption of EGF by A431 cells: evidence for receptor recycling. J. Cell Biol. 120: 85–93.
  • Mitra, A. B., V. V. Murty, M. Pratap, P. Sodhani, and R. S. Chaganti 1994. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix. Cancer Res. 54: 637–639.
  • Muller, K., F. O. Gombert, U. Manning, F. Grossmuller, P. Graff, H. Zaegel, J. F. Zuber, F. Freuler, C. Tschopp, and G. Baumann 1996. Rapid identification of phosphopeptide ligands for SH2 domains. Screening of peptide libraries by fluorescence-activated bead sorting. J. Biol. Chem. 271: 16500–16505.
  • Pang, L., T. Sawada, S. J. Decker, and A. R. Saltiel 1995. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270: 13585–13588.
  • Pelicci, G., L. Lanfrancone, A. E. Salcini, A. Romano, S. Mele, B. M. Grazia, O. Segatto, F. P. Di, and P. G. Pelicci 1995. Constitutive phosphorylation of Shc proteins in human tumors. Oncogene 11: 899–907.
  • Porfiri, E., and F. McCormick 1996. Regulation of epidermal growth factor receptor signaling by phosphorylation of the ras exchange factor hSOS1. J. Biol. Chem. 271: 5871–5877.
  • Rao, G. N. 1996. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. Oncogene 13: 713–719.
  • Rosette, C., and M. Karin 1996. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274: 1194–1197.
  • Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T. Hunt, and A. R. Nebreda 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78: 1027–1037.
  • Sachsenmaier, C., A. Radler-Pohl, R. Zinck, A. Nordheim, P. Herrlich, and H. J. Rahmsdorf 1994. Involvement of growth factor receptors in the mammalian UVC response. Cell 78: 963–972.
  • Schieven, G. L., and J. A. Ledbetter 1994. Activation of tyrosine kinase signal pathways by radiation and oxidative stress. Trends. Endocrinol. Metab. 5: 383–387.
  • Schieven, G. L., R. S. Mittler, S. G. Nadler, J. M. Kirihara, J. B. Bolen, S. B. Kanner, and J. A. Ledbetter 1994. ZAP-70 tyrosine kinase, CD45, and T cell receptor involvement in UV- and H2O2-induced T cell signal transduction. J. Biol. Chem. 269: 20718–20726.
  • Schlessinger, J. 1993. How receptor tyrosine kinases activate Ras. Trends Biochem. Sci. 18: 273–275.
  • Schmidt, C. M., I. H. McKillop, P. A. Cahill, and J. V. Sitzmann 1997. Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 236: 54–58.
  • Segatto, O., G. Pelicci, S. Giuli, G. Digiesi, F. P. Di, J. McGlade, T. Pawson, and P. G. Pelicci 1993. Shc products are substrates of erbB-2 kinase. Oncogene 8: 2105–2112.
  • Seger, R., and E. G. Krebs 1995. The MAPK signaling cascade. FASEB J. 9: 726–735.
  • Sivaraman, V. S., H. Wang, G. J. Nuovo, and C. C. Malbon 1997. Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest. 99: 1478–1483.
  • Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, and A. Ullrich 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712.
  • Snow, E. T. 1992. Metal carcinogenesis: mechanistic implications. Pharmacol. Ther. 53: 31–65.
  • Stein, C. A. 1993. Suramin: a novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res. 53: 2239–2248.
  • Szeberenyi, J., H. Cai, and G. M. Cooper 1990. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol. 10: 5324–5332.
  • Waters, S. B., K. H. Holt, S. E. Ross, L. J. Syu, K. L. Guan, A. R. Saltiel, G. A. Koretzky, and J. E. Pessin 1995. Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex. J. Biol. Chem. 270: 20883–20886.
  • Wiencke, J. K., J. W. Yager, A. Varkonyi, M. Hultner, and L. H. Lutze 1997. Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. Mutat. Res. 386: 335–344.
  • Yamauchi, T., K. Ueki, K. Tobe, H. Tamemoto, N. Sekine, M. Wada, M. Honjo, M. Takahashi, T. Takahashi, H. Hirai, T. Tushima, Y. Akanuma, T. Fujita, I. Komuro, Y. Yazaki, and T. Kadowaki 1997. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390: 91–96.
  • Zanella, C. L., J. Posada, T. R. Tritton, and B. T. Mossman 1996. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res. 56: 5334–5338.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.